Steroid synthesis is required for pregnancy maintenance and for parturition, but comparatively little is known about the major metabolic routes that influence circulating concentrations. Dietary intake changes progesterone and estradiol concentrations in pregnant ewes but whether this reflects placental synthesis is unknown. Progesterone metabolism by 5alpha-reduction is a major metabolic route in other species and can influence the onset of parturition. Therefore, studies were conducted to (1) determine placental enzyme activity, progesterone, and estradiol measured by immunoassay in late gestation ewes on low-, moderate-, and high-nutritional planes, (2) to assess the significance of 5alpha-reduction of progesterone in determining progesterone concentrations in late gestation ewes (gestation day 145) given finasteride to inhibit 5alpha-reductase metabolism. In the second experiment, steroid profiles were examined comprehensively in blood and tissues by liquid chromatography tandem mass spectrometry for the first time in this species. Dietary intake altered progesterone and estradiol serum concentrations but without correlated changes in placental 3beta-hydroxysteroid dehydrogenase, 17alpha-hydroxylase/17,20-lyase cytochrome P450 or aromatase activity. 5alpha-reduced pregnane metabolites were identified in ewes at 145 days of gestation, but concentrations were lower than those of progesterone. Finasteride inhibited 5alpha-reduced progesterone metabolism but did not impact serum progesterone concentrations in these ewes. We conclude that (1) diet-induced changes in serum progesterone and estradiol concentrations are not likely a result of altered placental synthesis of sex steroid but most likely by their metabolism, and (2) metabolism by 5α-reduction is not a major determinant of systemic progesterone concentrations in late gestation ewes.
Introduction
Steroid production is a fundamental requirement both for the maintenance of pregnancy and the delivery of healthy mammalian offspring. Pregnancy in most eutherians studied is reliant on continued support by progesterone from functionally active luteal tissue and the placenta later in pregnancy, most notably in sheep [1] as well as other species [2] [3] [4] . Conversely, parturition follows physiological progesterone withdrawal. This might result from one of several possible mechanisms including a decrease in progesterone concentration or a decline in progesterone receptor activation in responsive tissues of the reproductive tract [5] [6] [7] [8] . In addition, parturition in several species is preceded by an increase in estrogen concentrations. Several enzymes are required in the synthesis of progesterone and estrogens including 3β-hydroxysteroid dehydrogenase/ 5-4 isomerase (3βHSD), 17α-hydroxylase/17,20-lyase cytochrome P450 (P450c17), and aromatase cytochrome P450 (P450arom). The cellular sites and relative levels of the enzymes themselves can markedly alter rates of synthesis of steroids in the pathway in unexpected ways [9] . Additionally, these enzymatic activities are dependent on cofactors and accessory proteins or coenzymes [10] [11] [12] such that transcript data for the enzymes themselves may not accurately reflect changes in catalytic or metabolic rates. Hence, comparisons of actual catalytic activities may provide insight into which steps may limit steroid output in a way transcript analysis cannot and identify how output is regulated when steroid concentrations change under experimental or other conditions.
One of our laboratories noted in a previous study that dietary restriction and overfeeding altered serum progesterone and estradiol concentrations in pregnant sheep [13] . We also have shown previously that when ewes are undernourished (low intake) or overnourished (high intake) during pregnancy, they exhibit a 15-40% reduction in placental weight and blood flow, leading to reduced lamb birthweight compared with moderately fed ewes [14, 15] . Further, nutrient intake during pregnancy also affects maternal circulating estradiol concentrations, which are either similar or elevated in ewes on a low level of dietary intake, and are reduced in ewes on a high-intake level, when compared with ewes on a moderate level of intake [13, 16] . Hence, one aim of the studies reported here was to test the hypothesis that changes in dietary intake in pregnant ewes influence circulating progesterone and estradiol concentrations by altering steroidogenic enzyme activity. Thus, the aim of the first of these studies was to estimate and compare the activities of the above-mentioned, key enzymes in placentas from ewes on lowor high-intake diets to see if changes in serum steroid concentrations could be explained by alterations in placental steroid synthesis.
Steroid concentrations are determined not only by the rate of synthesis, but also by metabolism and clearance ( Figure 1 ). Although better recognized for their role in differentiation of the male external genitalia, a contribution for the 5α-reductases in the metabolism of progesterone during pregnancy has also been proposed [4] . In fact, some investigators considered it to be a major route of progesterone metabolism in the pregnant ewe [17] , although this has not been confirmed to the best of the authors' knowledge [18] . However, in pregnant mares, 5α-reduction of progesterone to 5α-dihydroprogesterone (DHP) is so extensive in the placenta that progesterone itself becomes undetectable in the second half of gestation [19] [20] [21] . In addition, knocking out the gene encoding 5α-reductase type 1 in mice disrupts pregnancy and parturition in that species [22] , suggesting that steroid 5α-reduction plays an important role in both maintenance and delivery. Since the transcript analysis of ovine placental tissues conducted in preliminary experiments indicated there was expression of 5α-reductase in ovine cotyledonary and caruncular tissues, a second major aim of the present studies was to re-examine concentrations of 5α-reduced pregnanes in pregnant ewes and their fetuses.
The physiological role of 5α-reduced pregnanes in different species will depend both on their relative biopotencies by way of progesterone receptor activation [20] and their ultimate concentrations [23] . Some metabolites that compete poorly for binding relative to progesterone may still exhibit bioactivity at much greater, but still physiologically relevant, concentrations. For instance, the 20α-hydroxy metabolite of DHP competes poorly with progesterone for binding in equine endometrial extracts, but physiological concentrations seen in mares in late gestation elicit a significant progestogenic response in vitro [23] . Similarly, a metabolite of DHP, allopregnanolone (3α-DHP; a product of DHP metabolism by aldo-keto reductase family 1 member C3 [AKR1C3]), has been shown to be a powerful inhibitor of the fetal HPA axis at the level of the hypothalamus [24] . To date, however, 5α-reduced pregnanes have received little scrutiny in cyclic or pregnant ewes, in part for lack of facile methods to measure these steroids. Hence, their role as progestins or their importance as a possible route for clearance of progesterone has not been assessed.
Therefore, additional studies were conducted to test the hypothesis that 5α-reduction of progesterone is a significant pathway for the metabolism of progesterone. Accordingly, the first aim of these studies was to investigate serum concentrations of 5α-reduced pregnanes and other steroids by liquid chromatography tandem mass spectrometry (LC-MS/MS) using a method developed recently to measure these and other steroids in horses [21] . The second aim of these studies was to explore the potential physiological importance of 5α-reduction of pregnanes in vivo was investigated by administering a 5α-reductase enzyme antagonist, finasteride, to ewes in late gestation to assess possible effects on progesterone concentrations.
Materials and methods

Animals
All animal use procedures were approved the North Dakota State University Institutional Animal Care and Use Committee (protocol #14001; PHS Animal Welfare Assurance #A3244-01).
In the first, preliminary study, samples of whole placenta, caruncle, and cotyledon were obtained at slaughter from ewes on gestation day (GD) 131-135 (day of mating = day 0; approximately 0.9 of gestation) that had been fed a control diet (100% of NRC recommendations [25] ). Based on these preliminary results which established appropriate assay conditions and confirmed that enzyme activity was found principally in cotyledonary tissue, a second study was conducted on cotyledonary samples obtained from ewes on low (60% of control, n = 7), moderate (100% control, n = 6), and high (140% of control, n = 7) dietary intake from day 40 after mating until slaughter at parturition.
Briefly, for the second study ewes were individually housed in 0.91-× 1.2-m pens in a temperature-controlled (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) o C), wellventilated facility for the duration of the study. Lighting within the facility was automatically timed to mimic ambient daylight patterns.
Nutrient requirements were based on NRC recommendations [25] for 60-kg pregnant ewes during mid to late gestation, and the diets were formulated to be similar in metabolizable energy and metabolizable protein and to meet or exceed other nutrient requirements, as we have described [26] . The pelleted diet consisted of dehydrated beet pulp, dehydrated alfalfa meal, soy hulls, ground corn, and soybean meal, and contained 2.63 Mcal/kg dry matter of metabolizable energy and a crude protein content of 14.4% of dry matter [26] . Ewes were assigned randomly to dietary intake group, and beginning on day 40 of mating nutritional plane for the low-and high-intake treatments was achieved by proportional downward or upward shifts in dietary intake, respectively, which resulted in global shifts in total nutrients supplied. Intake of the respective diets was calculated based on BW, which was measured every 14 days, at which times diets were adjusted accordingly. Individual daily allotments of diets were usually totally consumed, with the presence of orts at the next feeding being rare. For the final experiment examining progesterone metabolism by 5α-reductase, 19 pregnant ewes were randomly assigned to receive vehicle (20% ethanol in sesame oil; n = 4) or 0.5 (n = 5), 2.5 (n = 5), or 5.0 (n = 5) mg of finasteride (a potent 5 alpha reductase inhibitor) dissolved in vehicle. All doses were administered subcutaneously once daily from GD 135 to 145. The dose range was extrapolated from the dose administered orally to treat prostatic hyperplasia in men (5 mg/day [27] ). Systemic blood was collected from ewes and their fetuses at slaughter on day 145, and samples of caruncle and cotyledon were collected and snap-frozen for analysis of steroid concentrations by LC-MS/MS, steroidogenic enzyme activities, and expression of mRNA for steroidogenic enzymes.
Radioimmunoassay
Progesterone and estradiol concentrations in maternal systemic blood were determined by immunoassay in blood collected from ewes in the earlier studies. Progesterone was analyzed as previously described [28] . Briefly, 50 μL of maternal serum was analyzed in duplicate. Progesterone concentrations were measured by chemiluminescence immunoassay using the Immulite 1000 (Siemens, Los Angeles, CA). Cross-reactivity with other steroids is reported in the product insert to be <1% for tested compounds with the exceptions of deoxy-corticosterone (1.2%) and 11α-hydroxyprogesterone (1.04%). The intra-and interassay CV were 6.7% and 9.9%, respectively. Circulating concentrations of estradiol were analyzed in all serum samples by RIA as described [13, 29] . Interand intraassay CV were 4.2% and 4.6%, respectively. The assay sensitivity was 0.4 pg/mL.
Microsome preparation
Tissues were homogenized on ice in buffer (0.1 M potassium phosphate, pH 7.4, 20% glycerol, 5 mM β-mercaptoethanol and 0.5 mM phenylmethylethisulfinyl fluoride) at a ratio of approximately 1 mL buffer/0.1 g tissue. Microsomes were enriched by subcellular fractionation as previously described [11, 30] . Following a brief sonication, cellular debris and mitochondria were removed by centrifugation at 15 000× g for 10 min. The supernatant was removed and subjected to further centrifugation at 100 000× g for 60 min, and the pellet was resuspended in homogenization buffer containing 1 mM (3-[3-cholamidopropyl-dimethylammonio]-1-propanesulfonate; CHAPS). Microsomal protein concentration was determined using the Bicinchoninic Acid Protein Assay Reagent (Pierce, Rockford, IL). Aliquots of 100 μg were stored at -80
• C for steroidogenic enzyme expression and activity determinations as described below. The purity of microsomal fractions has been demonstrated by immunoblot analysis for microsomal and mitochondrial proteins [30] .
Microsomal enzyme activities
Microsomes (100 μg protein) were incubated for 60 min at 37
• C in phosphate buffer (50 mM K 3 PO 4 , 1 mM EDTA pH 7.4) with substrates (including 3 H-labeled steroid) and a generating system. Reactions for 3βHSD activity were supported with 1 mM βNAD. No 3βHSD activity was observed in reactions that included the NADPH generating system or in the absence of βNAD. For P450c17, reactions included a NADPH-generating system (1 mM NADP+, 10 mM glucose-6-phosphate, and 1.25 U glucose-6-phosphate dehydrogenase). Additional controls included inhibitors of 3βHSD (trilostane; Sterling-Winthrop, Renssaeler NY) and P450c17 (ketoconozole; 10 μM, Sigma Chemical Co., St. Louis MO). Reactions were terminated by the addition of 6 volumes of methylene chloride. The aqueous phase was removed, and the solvent was evaporated under nitrogen. Extracted steroids were separated by thin layer chromatography (TLC) on 0.2-mm glass-backed silica gel chromatography plates (E. M. Science, Gibbstown, NJ) in a chloroform-ethyl acetate (80:20) system. Products were identified by comigration with authentic standards that included dehydroepiandrosterone and androstenedione for 3βHSD activity, and progesterone and 17α-hydroxyprogesterone for activity catalyzed by P450c17 [9] , all obtained commercially (Steraloids, Wilton NH). The areas defined by the standards were scraped and counted by liquid scintillation spectroscopy. The 3βHSD activity was determined as a fraction of the sum of counts representing dehydroepiandrosterone plus androstenedione after subtraction of background (counts migrating with the androstenedione standard in reactions lacking microsomal protein). The activity catalyzed by P450c17 was determined from the amount of radioactivity that was associated with 17α-OH progesterone as a fraction of the radioactivity in the sum of progesterone and 17α-OH progesterone calculated similarly. Plasma samples (1 mL) were added to 13 × 100 glass screw top tubes followed by the addition of 100 μL of internal standard (IS) mixture (A 4 -d 7 , T 4 -d 3 , and P 4 -d 9 ) in methanol. Calibration standards ranging from 0.1 to 100 ng/mL were prepared simultaneously as the samples by adding the standard mix to charcoal stripped control serum and processed along with the samples. Five milliliters of methyl-tert buytl ether was added to the 1 mL of plasma and mixed for 15 min and centrifuged at 3000 g for 5 min. The resulting supernatant was transferred into a 12 × 75 glass tube and dried using a Zymark Turbovap concentrator (Hopkinton, MA, USA) at 45
• C with N2. Samples were reconstituted with 200 mL of 50:50 water and methanol and shaken for 1 min. For extraction of tissues, frozen specimens (0.25 g) were put in a 7-mL tissue grinding tube (Precellys, Rockville, MD) with 3.2-mm stainless steel beads. Four milliliters of methanol and water (50:50) were added to the grinding tube and shaken at 6500 rpm for 60 s using a Precellys tissue homogenizer. Samples were then stored for 20 min at -20
• and shaken again using the same parameters. The resulting slurry was transferred to a 13 × 100 glass screw top tube and dried to completion. The dried homogenate was reconstituted with 1 mL of water, and 100 μL of the IS mixture (A 4 -d 7 , T-d 3 , and P 4 -d 9 ) in methanol was added. Calibrators and four concentrations of quality control (QC) samples (0.6, 1.5, 20, and 80 ng/mL) were prepared alongside the unknown samples by adding the standards to water and processing them in parallel. Five milliliters of methyl-tert buytl ether was added to the reconstituted tissue homogenate, mixed for 15 min and centrifuged at 3000× g for 5 min. The resulting supernatant was transferred into a 12 × 75 glass tube and dried using a Zymark Turbovap concentrator (Hopkinton, MA) at 45
• C under N 2 . Samples were reconstituted with 200 μL of 50:50 water and methanol and shaken for 1 min. Calibration standards were run at the beginning and at the end of each sample set with QC samples. Quantitation of analytes was determined by linear regression analysis of the ratio of analyte area to the ratio of area of designated IS. Internal standards were chosen for each analyte based on the closest chemical structure and the analyte retention time. The method measured pregnenolone, progesterone, 17αOH-progesterone, DHP, and its metabolites 3αDHP, 20αDHP, 3β,20αDHP, as well as dehydroepiandrosterone, androstenedione, testosterone, DHT, estrone, and 19nor-androstenedione (Figure 1 ) as described previously [21] . In brief, reverse-phase gradient separation was performed on an Agilent Eclipse XDB-C18 analytical column (2.1 × 50 mm, 1.8 μm) with two mobile phases delivered at 0.4 mL/min, an injection volume of 20 μL and a column temperature of 40
• C. Mobile phases A and B were water with 0.2% formic acid and methanol, respectively. An elution gradient was held at 40% B for the first 0.2 min, 40-60% B from 0.2 to 1 min, 60-80% B from 1-10 min, 80-90% B from 10.0-10.1 min, 90% B from 10.1-11.1 min, 90-40% B from 11.1-11.2 min, and 40% B until 13.10 min. Ionization utilized an atmospheric pressure chemical ionization source in positive mode. Tandem mass spectral detection was accomplished using an Advance UHPLC LC coupled with a Bruker EVOQ Elite mass spectrometer. The assay was validated using the procedure defined in the FDA Guidelines for Industry Bioanalytical Method Validation. The concentration of all analytes in each sample (e.g., calibrators, QC, and unknowns) was determined for each analyte utilizing deuterated ISs by calculating the peak area ratio and using linear regression analysis. The responses for each analyte were linear with coefficients of determination (R 2 ) of ≥0.99. The limit of quantitation was defined at the lowest concentration of each steroid analyte quantified with precision of up to 20% and inaccuracy of ±20%. For each steroid, the calculated concentrations for intraday and interday precision (% relative standard deviation) and accuracy (% of nominal concentration) of six replicate analysis of the 1.5, 20, and 80 ng/mL QC samples. The evaluation of precision and accuracy revealed coefficients of variation and percent inaccuracy of <15%.
Quantitative PCR
Expression levels of transcripts encoding steroid synthesizing and metabolizing enzymes were determined by quantitative RT-PCR using SYBR green chemistry and the Ct method [31] as previously described [32] . All samples were compared to a sheep reference pool comprised of RNA isolated from adult sheep corpus luteum, granulosa, and thecal cells, and adrenal gland. In addition, expression of β-actin was used as the endogenous reference control. The primer sequences used are shown in Table 1 .
Statistical analysis
Levels of statistical significance were assessed using the Mixed Models procedure of SAS (SAS Inst. Inc., Cary, NC) for differences in concentrations among steroids detected and main effects of, and interactions with, treatment. Dose-dependent effects of finasteride were examined by regression analysis using the General Linear Models procedure and correlations were examined using Proc Corr.
Results
Preliminary studies were conducted on placentas from sheep at GD 131-135 (0.90 of gestation) to examine the principal site of 3βHSD, P450c17, and P450arom activities (cotyledon vs caruncle) and to establish reaction conditions for which product accumulation was linear. Inhibitors of 3βHSD (trilostane, 10 μM; 90.4% inhibition), P450c17 (ketoconazole; 10 μM; 84% inhibition), and P450arom (letrozole; 10 μM; >99% inhibition) added to each of these reactions confirmed that product accumulated as a result of the specific enzyme activity being measured. In all cases, the principal site of enzyme activity was in cotyledonary microsomes (data not shown) and these were used for enzyme activities thereafter. 
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Figure 1. Schematic depicting steroidogenic (synthesis and metabolism) pathways from pregnenolone to progesterone and its 20αOH-, 17αOH-, and 5α-reduced metabolites (5α-reduced pregnanes), and to dehydroepiandrosterone, androstenedione, and testosterone (androgens), and finally estrone and estradiol (estrogens). Progesterone and estradiol were measured by immunoassay in initial experiments. All steroids appearing in bold lettering were included (though not all were detected) in an analysis by liquid chromatography tandem mass spectrometry (LC-MS/MS) of serum from ewes in late gestation examining effects of finasteride, a known inhibitor of 5α-reductase enzyme activity, on steroid profiles. The enzymes 3β-hydroxysteroid dehydrogenase (3βHSD), 5α-reductase (italics), 17α-hydroxylase/17,20-lyase (P450c17), and aromatase (P450arom) cytochrome P450 are depicted in italics. STAR  GGAGAGCCGGCAGGTCAATG  CTTCTGCAGGACCTTGATCTCCTTG  NM 001009243  CYP11A1  AGAGAATCCACTTTCGCCACATC  GGTCTTTCTTCCAGGTTCCTGAC  K02130  FDX1  TGATGGTTTTGGTGCATGTGA  TGCTGTTCAAAGATGAGGTGACA  NM 181011  FDXR  GTGAGCCTCATCCCGACCT  CATCCAGAGCCACGTTCCC  XM 012186556  HSD3B1  TGTTGGTGGAGGAGAAGGATCTG  TGGGTACCTTTCACATTGACGTTC  Z82978  CYP17A1  TGATGATTGGACACCACCAGT  AGAGAGAGAGGCTCGGACAGATC  NM 001009483  CYP19A1  CAGAGAAGCTGGAAGACTGCATAG  ACCACGTTTCTCGGCAAA  NM 001123000  SRD5A1  CTGGCCCAACTGCATCCT  AGGTCCGTTGCGCATAGTG  XM 012147323  SRD5A2  GGAGGCCGTTTCCAGTTGTA  AGTCCATTTCCCATGCAGAAGA  XM 012173594  AKR1C1  GGAAAGCGGATAGTCAGGGTGATC  GCCATTGCCAAAAAGCACAAG  NM 00116766  AKR1C3  TCCCAACAGATGAAAATGGAAA  GCCTCCCACGTGAGACAGA  XR 001044514  ACTB  TGTCCACCTTCCAGCAGATGT  AGCTCAGTAACAGTCCGCCTAGA  NM 001009784 a All gene names taken from the HUGO Gene Nomenclature Committee (HGNC) website. b Nucleotide sequences used for primers were obtained from the National Center for Biotechnology Information (NCBI) database.
The relationship between serum progesterone and estradiol concentrations and 3βHSD, P450c17, and P450arom activities in cotyledonary tissue was examined at slaughter in ewes fed diets representing low, moderate, and high intake. Cotyledonary microsomes from the placentas of these ewes demonstrated that 3βHSD activity was generally greater than P450c17 activity but of similar magnitude. Conversely, P450arom enzyme activities were considerably lower than those of either 3βHSD or P450c17 (Figure 2 ). The level of dietary intake did not affect placental enzyme activities (Figure 2) , nor was there any correlation between 3βHSD, P450c17, or P450arom activities and either progesterone or estradiol concentrations in systemic blood. Though not significantly different, in general, placental 3βHSD and P450c17 enzyme activities were lower in the ewes on the moderate intake diet than in those on either the low or the high intake, whereas jugular progesterone concentrations decreased progressively as dietary intake increased (Table 2) . Despite no effect of dietary intake on placental steroidogenic enzyme activities, when jugular blood samples from low-, moderate-and high-intake ewes were analyzed by immunoassay, the lowest progesterone and estradiol concentrations in maternal systemic blood were in the high intake compared with the low-intake ewes, with moderate-intake ewes having intermediate levels ( Table 2 ).
In the last experiment, we utilized inhibition of 5α-reductase by finasteride to investigate the impact of metabolism through this pathway on steroid synthesis and secretion in ewes in late gestation. As shown in Figure 3 , progesterone concentration was the greatest of the measured steroids, significantly greater than pregnenolone (P < 0.001), and both progesterone and pregnenolone concentrations were significantly greater than those of the only two detected unconjugated 5α-reduced pregnanes, DHP (P < 0.001), and allopregnanolone (3α-DHP, P < 0.001). There was no effect of finasteride treatment on serum concentrations of either progesterone or pregnenolone. Serum allopregnanolone concentrations were significantly greater than DHP concentrations in the vehicle group (P < 0.001), and there was a significant main effect of finasteride treatment on serum allopregnanolone concentrations (P < 0.05). Although the inhibition of allopregnanolone was not detectably dosedependent by linear regression analysis, serum allopregnanolone concentration was significantly inhibited at the 5 mg/kg dose of finasteride compared with vehicle treatment (P < 0.01). There was no main effect of finasteride treatment on serum DHP concentrations, nor was there a significant dose-dependent effect of finasteride by linear regression analysis, though there appeared to be a trend (P < 0.09). Other steroids including 17OH-progesterone, Figure 4 . Caruncular (CAR) and cotyledonary (COT) tissue concentrations (ng/mg) of steroids in late pregnant ewes treated with finasteride, a known inhibitor of 5α-reductase enzyme activity. Tissues were extracted and analyzed by LC-MS/MS (see Materials and Methods) which detected the steroids shown: pregnenolone, progesterone, 5α-dihydroprogesterone (DHP), and allopregnanolone.
* * Differs between tissues, P < 0.01; * differs between tissues, P = 0.06.
androstenedione, and 19nor-androstenedione were detected in maternal serum in much lower concentrations than progesterone, pregnenolone, allopregnanolone, or DHP and were unaffected by finasteride. Lower concentrations of all of these same steroids were detected in fetal blood. Averaged across all groups, pregnenolone, progesterone, and DHP were 5-10-fold higher in maternal than fetal blood, none of which was affected by finasteride (data not shown). Steroid tissue concentrations were also investigated in finasteridetreated and control ewes ( Figure 4 ) and were broadly reflective of maternal serum concentrations. Tissue concentrations of pregnenolone were similar in cotyledonary and caruncular tissues, averaging 137.80 ± 9.20 ng/gm and were similar to progesterone concentrations. However, average of cotyledonary and caruncular tissue pregnenolone and progesterone concentrations were generally greater than were those of DHP and allopregnanolone. Progesterone concentrations were significantly greater in cotyledonary than caruncular tissue (P < 0.01) and allopregnanolone tended to be greater in caruncular tissue (P = 0.06). Although there was no overall effect of finasteride treatment, cotyledonary tissue concentrations of DHP were dose-dependently inhibited by finasteride (P = 0.05; Figure 4 ) based on linear regression analysis. The DHP metabolite 3β,20α-DHP was detected in caruncular tissue, but there was no effect of finasteride on caruncular concentrations and none was detected in cotyledonary tissues (data not shown).
There was no effect of finasteride treatment and no finasteride by tissue interaction on the abundance of any of the transcripts examined in placental tissues, and data were therefore combined across finasteride treatment groups (Table 3) . Transcript analysis was generally consistent with enzyme activity analyses in the placental tissues. That is, gene expression for the enzymes 3βHSD, P450c17, and P450arom was respectively 3.6-fold (HSD3B1; P < 0.001), 13.5-fold (CYP17A1; P < 0.08), and 9.1-fold (CYP19A1; P < 0.001) greater in cotyledonary compared with caruncular tissue (Table 3) . Cotyledon also exhibited the greatest levels of transcripts encoding STAR (steroidogenic acute regulator) and side chain cleavage cytochrome P450 (CYP11A1) expression (P < 0.001; Table 3 ). Conversely, caruncular tissue expressed the greatest levels of transcripts encoding for 5α-reductase (SRDA1 and SRDA2; P < 0.01) and aldoketo-reductase enzymes (AKR1C1 and AKR1C3; P < 0.01; Table 3 ). Table 1 .
Discussion
The results of the present studies indicate that the changes in maternal progesterone and estradiol concentrations associated with differences in dietary intake do not result from corresponding shifts in steroid synthetic enzyme activities in placental tissues. Diet-induced changes in circulating steroid concentrations, as previously reported [13] , did not correlate with placental enzyme activities, which were not changed by diet. It seems unlikely therefore that any diet-related influence on placental steroidogenesis can adequately explain alterations in progesterone or estrogen concentrations in pregnant ewes. The estimates of 3βHSD activity, as reported here, were slightly greater than those reported by others [1] , probably due in part to the fact that our studies were conducted on purified microsomes and theirs on whole placental homogenates. But still, none of these enzyme activities correlated with the observed changes in concentrations of progesterone and estradiol caused by diet; specifically, increasing dietary nutrient intake progressively depressed both progesterone and estradiol concentrations. In contrast, placental enzyme activities were generally greater in ewes on low and on high planes of nutrition, and lower in ewes on the moderate plane of nutrition. Therefore, we conclude that the decrease in plasma steroid concentrations seen with increasing nutrient intake in pregnant ewes is likely not due to changes in placental enzyme activities or steroid synthesis but more likely changes in extra-placental steroid metabolism, possibly related to changes in hepatic blood flow and steroid clearance [33] [34] [35] [36] .
The proposal that 5α-reduction is a major pathway for progesterone metabolism in pregnant ewes [17] was not supported by the results of the current investigation. First, 5α-reduced pregnanes were detected in the pregnant ewes at much lower concentrations than progesterone or pregnenolone. Although transcript analysis confirmed expression of SDR5A1 in placenta, the fetal hypothalamus appeared to have much greater expression levels than either caruncular or cotyledonary tissues (unpublished observations). Others examining hepatic metabolism of progesterone in sheep did not report finding high levels of 5α-reduced pregnanes [37] . Most convincingly, finasteride administration dose-dependently decreased concentrations of allopregnanolone, the 5α-reduced pregnane that was detected in highest concentrations in maternal serum, but failed to increase progesterone concentrations. In contrast to sheep, treatment of late gestation mares with dutasteride, another potent antagonist of 5α-reductase metabolism, significantly increased circulating progesterone concentrations [38] . Collectively, the results presented here indicate that in the pregnant ewe progesterone metabolism does not involve the 5α-reductases as a significant component, even if changes in progesterone (and estradiol) concentrations are affected through altered hepatic clearance as a result of dietary intake.
It has long been known that, in addition to progesterone, there are substantial concentrations of a direct metabolite of progesterone, 20α-hydroxy-pregn-4-en-3-one (20αOH-P4), in systemic blood of pregnant ewes throughout gestation [39] , which we have since confirmed by LC-MS/MS. Progesterone and 20αOH-P4 were found to be present in similar concentrations which changed in parallel throughout gestation (unpublished observations). However, 20αOH-P4 is not presumed to be an active progestin, and discrepancies between chemical and biological estimates of progestin concentrations have therefore fueled speculation that other, possibly potent, metabolites might indeed exist [39, 40] . Despite the estimates of almost equal plasma concentrations of these two pregnanes, some have proposed nonetheless that 20αOH-P4 is likely a minor metabolite Downloaded from https://academic.oup.com/biolreprod/article-abstract/99/3/662/4970762 by OUP site access user on 04 October 2018 [18] . Gauging the importance of 20α-hydroxylation as a significant route of progesterone clearance would require the identification of the enzyme involved and the development and use of a specific inhibitor of it.
There is considerable variation in the ways in which progesterone is metabolized during pregnancy in mammals, as well as the relative degree and importance of different routes, even among closely related species. Goats, a close relative of sheep, exhibit very high concentrations of 5β-reduced pregnanes during gestation [41] , though what specific tissues are the sites of metabolism is unknown. Still, there appears to be a broad range of mammalian species that do metabolize progesterone utilizing 5α-reductase as a principal route. Besides horses [19, 21] and zebras [42] , several species, including humans, appear to utilize 5α-reduction as a major route of progesterone metabolism during gestation. Systemic concentrations of DHP are substantial in pregnant women [43, 44] , as in elephants [45] and hyrax [46] , and even manatees [47] among the cetartiodactyla. Therefore, like these species, it seems possible that other ruminants, or other artiodactyls, will be found to exhibit extensive 5α-reductase metabolism of progesterone during pregnancy but that it is not easily predicted based on phylogeny.
In summary, in the studies reported here, little evidence was found that metabolism by 5α-reduction of progesterone is significant in reproductive tissues of the pregnant ewe, though other steroidogenic enzyme activities were confirmed. Clearly, major differences exist among species in this regard. The metabolism of progesterone by 5α-reduction is high in equine and human pregnancies [8] for instance. Despite earlier work [17] and speculation from preliminary studies by the authors [4] , the major route of progesterone metabolism in the pregnant ewe remains to be defined.
